Keppra Solution
Product Images NDC 50474-001

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Keppra (NDC 50474-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ucb, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Keppra 01)

Chemical structure diagram of levetiracetam, the active ingredient in Keppra. The structure shows a pyrrolidone ring with an ethyl side chain and an amide functional group attached to the chiral carbon.*

FDA Label Image

Figure 1 (Keppra 02)

A bar graph comparing the percentage of patients across three groups receiving placebo, Keppra 1000 mg/day, and Keppra 3000 mg/day. The y-axis shows the percentage of patients, with Keppra 3000 mg/day group having the highest percentage near 40%, followed by Keppra 1000 mg/day at about 37%, and placebo at approximately 7.4%. Each bar is labeled with the exact percentage and patient count.*

FDA Label Image

Figure 2 (Keppra 03)

A bar chart comparing the percentage of patients under three different treatments: Placebo, Keppra 1000 mg/day, and Keppra 2000 mg/day. The y-axis represents the percentage of patients, showing increasing values from Placebo (6.3%) to Keppra 1000 mg/day (20.3%) and Keppra 2000 mg/day (35.2%).*

FDA Label Image

Figure 3 (Keppra 04)

Bar chart comparing the percentage of patients between a placebo group and a group treated with Keppra 3000 mg/day. The y-axis represents the percentage of patients, showing higher response in the Keppra group (39.4%) compared to placebo (14.4%). Sample sizes are indicated as N=104 for placebo and N=180 for Keppra.*

FDA Label Image

Figure 4 (Keppra 05)

A bar chart comparing the percentage of patients between a placebo group (19.6%) and a Keppra (levetiracetam) group (44.6%). The x-axis shows the groups (Placebo N=97, Keppra N=101) and the y-axis represents the percentage of patients, ranging from 0% to 45%.*

FDA Label Image

Figure 5 (Keppra 06)

A bar chart comparing the percentage of patients between Placebo (N=51) and Keppra (N=58). The y-axis shows the percentage of patients from 0% to 45%. The Placebo bar reaches 19.6%, while the Keppra bar reaches 43.1%, with an asterisk above the Keppra bar.*

FDA Label Image

Figure 6 (Keppra 07)

A bar chart comparing the percentage of patients between a placebo group and a Keppra group. The placebo group shows 45.2% of patients, while the Keppra group shows 72.2%, with patient counts of 84 and 79 respectively. The graph highlights a higher percentage in the Keppra group.*

FDA Label Image

Principal Display Panel (250 mg Tablet Bottle Label)

Label for Keppra (levetiracetam) 250 mg film-coated tablets, oral use, containing 120 tablets per package. The label includes storage instructions, dispensing guidance, and FDA-required medication guide advisory. Manufactured for UCB, Inc., Smyrna, GA. NDC 50474-594-40 is visible.*

FDA Label Image

Principal Display Panel (500 mg Tablet Bottle Label)

Keppra (levetiracetam) 500 mg film-coated tablets label. The label indicates a package containing 120 tablets, with storage instructions to keep at 25°C (77°F), and dispensing in a child-resistant container. The labeler is UCB, Inc., Smyrna, GA, and it notes Keppra as a registered trademark of UCB S.A. Includes barcode and NDC 50474-595-40.*

FDA Label Image

Principal Display Panel (750 mg Tablet Bottle Label)

Keppra (levetiracetam) 750 mg tablets label showing the product name, strength, quantity of 120 tablets, NDC 50474-596-40, storage instructions for controlled room temperature, and manufacturer information for UCB, Inc. The label also includes a barcode, pharmacist dispensing instructions, and trademark details.*

FDA Label Image

Principal Display Panel (1000 mg Tablet Bottle Label)

Label for Keppra (levetiracetam) 1000 mg film-coated tablets. The label displays the NDC 50474-597-66 and indicates a package of 60 tablets. It includes instructions to dispense a medication guide with each patient and storage guidelines, with UCB, Inc. as the manufacturer in Smyrna, GA.*

FDA Label Image

Principal Display Panel (473 mL Bottle Label)

Keppra (levetiracetam) 100 mg/mL oral solution label showing dosage instructions to see package insert, NDC 50474-001-48, and a 16 fl oz (473 mL) container size. The label includes pharmacist storage and dispensing information, manufacturer UCB, Inc., and safety warnings.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.